Izotropic Corporation (IZO.CN)

CAD 0.04

(-20.0%)

EBITDA Summary of Izotropic Corporation

Izotropic Corporation's latest annual EBITDA in 2023 was -1.6 Million CAD , up 69.82% from previous year.
Izotropic Corporation's latest quarterly EBITDA in 2024 Q1 was -1.18 Million CAD , down -1657.55% from previous quarter.
Izotropic Corporation reported an annual EBITDA of -5.32 Million CAD in 2022, up 19.89% from previous year.
Izotropic Corporation reported an annual EBITDA of -6.62 Million CAD in 2021, down -33.25% from previous year.
Izotropic Corporation reported a quarterly EBITDA of -230.54 Thousand CAD for 2023 Q3, up 65.7% from previous quarter.
Izotropic Corporation reported a quarterly EBITDA of N/A for 2023 FY, up 69.11% from previous quarter.

Annual EBITDA Chart of Izotropic Corporation (2023 - 2016)

Historical Annual EBITDA of Izotropic Corporation (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	-1.6 Million CAD	69.82%
2022	-5.32 Million CAD	19.89%
2021	-6.62 Million CAD	-33.25%
2020	-4.97 Million CAD	-331.6%
2019	-1.15 Million CAD	-194.02%
2018	-391.99 Thousand CAD	44.07%
2017	-700.87 Thousand CAD	-864.21%
2016	- CAD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-1.18 Million CAD	-1657.55%
2023 Q3	-230.54 Thousand CAD	65.7%
2023 FY	- CAD	69.11%
2023 Q1	-415.36 Thousand CAD	65.31%
2023 Q2	-672.06 Thousand CAD	-61.8%
2023 Q4	-322.76 Thousand CAD	-40.0%
2022 Q2	-1.29 Million CAD	-34.18%
2022 Q1	-961.54 Thousand CAD	40.74%
2022 FY	- CAD	19.89%
2022 Q4	-1.19 Million CAD	37.22%
2022 Q3	-1.9 Million CAD	-47.8%
2021 Q2	-2.55 Million CAD	-108.61%
2021 Q3	-1.22 Million CAD	51.83%
2021 Q4	-1.62 Million CAD	-31.96%
2021 FY	- CAD	-33.25%
2021 Q1	-1.22 Million CAD	35.76%
2020 Q2	-370.9 Thousand CAD	17.28%
2020 FY	- CAD	-331.6%
2020 Q4	-1.9 Million CAD	15.35%
2020 Q3	-2.25 Million CAD	-506.7%
2020 Q1	-448.4 Thousand CAD	25.8%
2019 Q2	-154.56 Thousand CAD	-6.16%
2019 FY	- CAD	-194.02%
2019 Q4	-604.33 Thousand CAD	-143.61%
2019 Q1	-145.59 Thousand CAD	-6.27%
2019 Q3	-248.07 Thousand CAD	-60.5%
2018 Q2	-92.74 Thousand CAD	-7.51%
2018 Q3	-75.98 Thousand CAD	18.08%
2018 Q4	-137 Thousand CAD	-80.32%
2018 FY	- CAD	44.07%
2018 Q1	-86.26 Thousand CAD	43.61%
2017 Q3	-67.15 Thousand CAD	83.57%
2017 Q4	-152.96 Thousand CAD	-127.77%
2017 FY	- CAD	-864.21%
2017 Q1	-72.07 Thousand CAD	-157.78%
2017 Q2	-408.66 Thousand CAD	-466.99%
2016 Q2	- CAD	0.0%
2016 Q1	- CAD	0.0%
2016 Q4	-27.96 Thousand CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q3	- CAD	0.0%

Peer EBITDA Comparison of Izotropic Corporation

Name	EBITDA	EBITDA Difference
BioMark Diagnostics Inc.	-1.11 Million CAD	-44.064%
Sona Nanotech Inc.	-2.01 Million CAD	20.49%